I'm the Founder, Owner, and CEO of Dr. Holger Engel - CONSULTING, offering Technology and Business Consultancy Services in Life Science and Molecular Diagnostics - Molecular Technologies Strategy to Product.Building on 25+ years of expertise in the market of the Technology Segment of Nucleic Acid Amplification and Detection Solutions, my Consultancy Services are driven by transforming great ideas into products. • Building & Successfully Executing Idea to Product Strategies: Systemic View from Product Idea to Business & Market Entry Strategy for Diagnostic Products, Life Science Tools, and Applied Markets. R&D, Product Development: Molecular Technologies – Streamlining Time, Decision Steps, Costs from Idea to Commercialization. • Manufacturing: Design, Planning, Execution of Manufacturing Lines and Processes for Consumable (Microfluidic / Millifluidic) Cartridges, Kits, and Reagents. • Coaching & Interim Management – Supporting in Building up Start-ups, Product Realization, Project & Program Management, Getting Started in Manufacturing (In-house or Outsourced). • Selection & Management of Suppliers and Outsourced Development & Manufacturing. • Efficiency & Effectiveness R&D & Quality Processes. • Additional Offerings, Partly in Cooperation through a Network of Partners: • Manufacturing - Line or Site Management. • Quality Processes, Design Control. • Company Creation, Financing, Technical Due Diligence & Post Merger Integration. • Market Intelligence: Identifying Key Opinion Leaders and Qualified Leads (e.g., Users of Competing Products).See www.holgerengel.com or the LinkedIn Company Page Dr. Holger Engel - CONSULTING for more details. Links below in this section. Contact Email: info@holgerengel.com

Ambiatec intends to contribute making precise molecular diagnostics accessible everywhere.Contact us at info@ambiatec.com to explore partnering or investment opportunities.

Director of Reagents at STAT-Diagnostica, now called STAT-Dx, exit to QIAGEN in April 2018.Sample-to-Result System for Point-of-Need/Point-of-Care Diagnostics - now called the QIAstat-Dx System. See video linked below for more information.- Responsible lead of all reagents & application related activities of the company. Building & heading the company’s reagents R&D team.- Senior management team member, building strategy and interacting with investors & possible acquirers. Reporting to CEO and Board of Directors.- Managing Point-of-Care System development – system integration and application development for the development of a Point-of-Care Diagnostic Sample-to-Result-System for human diagnostics, molecular diagnostics and immuno assay.- Building company infrastructure for transition from research to manufacturing of IVD Medical Device products.- Business Development: Building and managing network of development & cooperation partners, KOL’s, patent lawyers, consultants, suppliers, and potential future partners/acquirers of the company. - Negotiating development, licensing, technology acquisition, supply and quality contracts. - Managing Scientific affairs activities of the company including Verification & Validation (clinical) Studies.

Head of Applied Testing R&D (Human Identity & Forensics, Food Safety and Veterinary Testing).- Creating & Leading QIAGEN’s Applied Testing R&D competence center.- Member of Applied Testing Management Core Team – Driving market strategy, & business planning for the customer segment. - Market-Program and project management in a multi-national matrix organization and with external development and manufacturing partners. Budget responsibility.- Core team member of a series of merger & acquisition projects and post-merger integration.- Management of key opinion leaders and cooperation’s. Leading negotiations for Development – Licensing and Supply Contracts- Design, development & Commercialization of product offerings for Human Identity, Food Safety, and Veterinary Diagnostics, and development of technologies for human Molecular Diagnostics.- Reporting to VP Life Science R&D (solid line), VP Applied Testing Business (dotted line), quarterly reports to QIAGEN’s senior executive team.- Alumnus of QIAGEN Management Campus program (Mini-MBA-like program).

Head of R&D competence Center for Applied Testing (Human Identity & Forensics, Food Safety and Veterinary Testing)

Senior Scientist in R&D competence center Modification & Amplification.- Life Science R&D: Senior Scientist R&D Apr 2006-Mar 2009 (3 years), Scientist R&D Feb 2001-Mar 2006 (5 years 2 months).- Building & leading R&D team & Project management from idea to commercial product.- Leading international, multidisciplinary teams, and direct interaction with the target customers.- Internal consultant for IVD Assay Amplification Reagents.- Successful market introduction of 15 assay technology products for a broad application range including all types of multiplex analysis for gene expression, genotyping, micro-RNA detection & pathogen detection.- Series of awards for product- and technology innovations.

Scientist in R&D competence center Modification & Amplification